Largest market shown
Germany
$180.4B calculated opportunity across 45 screened products.
Regional export playbook
Spain in Europe
where to look next
Compare buyer markets, access conditions, and product opportunities across Europe. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.
3-year opportunity$951.6BCalculated addressable value
Buyer markets26Markets with qualifying rows
FTA markets23Reported access indicator
Avg. distance1,854 kmAverage reported distance
Avg. entry days10Business entry indicator
Europe regional view
Should Spain focus here?
The answer depends on demand, product fit, access, competition, and route economics. This playbook shows where the available trade signals are strongest.
Regional footprint
26 buyer markets
Reported trade and access indicators are available for the qualifying markets shown below.
How to use the guide
Compare demand with access
Start with the strongest markets, then validate buyers, tariffs, standards, logistics, and competition at product level.
Market comparison
Which markets deserve a closer look?
Markets are ranked by calculated three-year opportunity across the qualifying products in this regional view.
| Market | Opportunity | Products | FTA | Distance | Entry days | Top product |
|---|---|---|---|---|---|---|
| GermanyDEU | $180.4B | 45 | Reported | 1,479 km | 8 | Electric accumulators: lithium-ion, including separators, whether or not rectangular (including square) |
| NetherlandsNLD | $122.4B | 28 | Reported | 1,481 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| United KingdomGBR | $121.9B | 28 | Reported | 1,263 km | 5 | Metals: gold, non-monetary, unwrought (but not powder) |
| BelgiumBEL | $85.1B | 15 | Reported | 1,317 km | 5 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Switzerland, LiechtensteinCHE | $83.5B | 10 | Reported | 1,153 km | 10 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| FranceFRA | $67.8B | 22 | Reported | 1,055 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| ItalyITA | $60.1B | 13 | Reported | 1,367 km | 11 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| SloveniaSVN | $42.7B | 6 | Reported | 1,601 km | 8 | Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof |
| RussiaRUS | $41.1B | 9 | Not reported | 3,449 km | 10 | Vehicles: spark-ignition internal combustion reciprocating piston engine, cylinder capacity exceeding 1500cc but not exceeding 3000cc |
| PolandPOL | $34.4B | 12 | Reported | 2,293 km | 37 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| CzechiaCZE | $19.2B | 8 | Reported | 1,776 km | 25 | Telephones for cellular networks or for other wireless networks |
| IrelandIRL | $15.7B | 5 | Reported | 1,450 km | 11 | Aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg |
| HungaryHUN | $14.5B | 6 | Reported | 1,978 km | 7 | Aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg |
| AustriaAUT | $10.4B | 5 | Reported | 1,812 km | 21 | Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions |
| DenmarkDNK | $8.0B | 3 | Reported | 2,075 km | 4 | Vehicles: with only electric motor for propulsion |
| GreeceGRC | $7.0B | 2 | Reported | 2,373 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| MaltaMLT | $5.8B | 2 | Reported | 1,671 km | 21 | Vessels: n.e.s. in heading no. 8901, for the transport of goods and other vessels for the transport of both persons and goods |
| NorwayNOR | $5.6B | 2 | Reported | 2,391 km | 4 | Vehicles: with only electric motor for propulsion |
| SlovakiaSVK | $4.9B | 2 | Reported | 1,866 km | 22 | Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas |
| FinlandFIN | $4.7B | 1 | Reported | 2,952 km | 13 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| SwedenSWE | $4.3B | 2 | Reported | 2,597 km | 8 | Vehicles: with only electric motor for propulsion |
| LithuaniaLTU | $2.9B | 1 | Reported | 2,666 km | 6 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| UkraineUKR | $2.8B | 2 | Reported | 2,864 km | 7 | Ammunition: n.e.s. in chapter 93 |
| PortugalPRT | $2.7B | 1 | Reported | 501 km | 7 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| RomaniaROU | $2.1B | 1 | Not reported | 0 km | 0 | Vehicles: parts, gear boxes |
| BelarusBLR | $1.5B | 1 | Not reported | 2,763 km | 9 | Vehicles: with only spark-ignition internal combustion piston engine, cylinder capacity over 1000 but not over 1500cc |
Top regional opportunities
Products and markets to review
The rows below are screened by reported buyer demand, exporter position, and available history. Calculated opportunity is a research signal, not a forecast.
| Rank | Market | Product | Opportunity | Buyer growth | Current share |
|---|---|---|---|---|---|
| 1 | United KingdomGBR | HS 710812Metals: gold, non-monetary, unwrought (but not powder) | $24.2B | +15.3% | +1.8% |
| 2 | Switzerland, LiechtensteinCHE | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $23.2B | +12.3% | +7.8% |
| 3 | BelgiumBEL | HS 270900Oils: petroleum oils and oils obtained from bituminous minerals, crude | $20.7B | +7.6% | +0.0% |
| 4 | GermanyDEU | HS 850760Electric accumulators: lithium-ion, including separators, whether or not rectangular (including square) | $19.8B | +19.2% | +0.0% |
| 5 | NetherlandsNLD | HS 270900Oils: petroleum oils and oils obtained from bituminous minerals, crude | $18.5B | +6.5% | +0.0% |
| 6 | Switzerland, LiechtensteinCHE | HS 710813Metals: gold, semi-manufactured | $17.1B | +14.3% | +0.1% |
| 7 | Switzerland, LiechtensteinCHE | HS 710812Metals: gold, non-monetary, unwrought (but not powder) | $17.0B | +12.8% | +0.3% |
| 8 | GermanyDEU | HS 271121Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas | $16.4B | +4.2% | +0.0% |
| 9 | United KingdomGBR | HS 270900Oils: petroleum oils and oils obtained from bituminous minerals, crude | $14.4B | +5.5% | +0.0% |
| 10 | ItalyITA | HS 270900Oils: petroleum oils and oils obtained from bituminous minerals, crude | $12.9B | +5.3% | +0.2% |
| 11 | BelgiumBEL | HS 271019Product description unavailable | $12.6B | +9.1% | +1.2% |
| 12 | RussiaRUS | HS 870323Vehicles: spark-ignition internal combustion reciprocating piston engine, cylinder capacity exceeding 1500cc but not exceeding 3000cc | $12.2B | +12.7% | +0.1% |
| 13 | GermanyDEU | HS 271019Product description unavailable | $12.1B | +5.8% | +1.1% |
| 14 | ItalyITA | HS 293719Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts | $11.7B | +29.0% | +0.1% |
| 15 | SloveniaSVN | HS 293359Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $11.3B | +34.8% | +0.0% |
| 16 | NetherlandsNLD | HS 271019Product description unavailable | $11.1B | +12.2% | +2.1% |
| 17 | SloveniaSVN | HS 293399Heterocyclic compounds: n.e.c. in headings no. 2933 | $10.5B | +30.0% | +0.0% |
| 18 | PolandPOL | HS 270900Oils: petroleum oils and oils obtained from bituminous minerals, crude | $9.9B | +8.1% | +0.0% |
| 19 | GermanyDEU | HS 851712Telephones for cellular networks or for other wireless networks | $9.7B | +9.2% | +0.2% |
| 20 | SloveniaSVN | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $9.6B | +17.9% | +0.7% |
Sector opportunities
Which product families lead?
HS2 groups make it easier to compare broad product families before moving to individual HS6 products.
HS2 27
HS2 sector 27
30 screened products with $343.4B of reported buyer imports.
$183.1BCalculated opportunity · +12.1% average growthHS2 30
HS2 sector 30
35 screened products with $284.2B of reported buyer imports.
$138.1BCalculated opportunity · +13.4% average growthHS2 85
HS2 sector 85
31 screened products with $186.1B of reported buyer imports.
$116.7BCalculated opportunity · +12.4% average growthHS2 87
HS2 sector 87
35 screened products with $180.8B of reported buyer imports.
$116.5BCalculated opportunity · +24.1% average growthHS2 71
HS2 sector 71
11 screened products with $221.4B of reported buyer imports.
$79.0BCalculated opportunity · +9.4% average growthHS2 00
HS2 sector 00
16 screened products with $158.3B of reported buyer imports.
$72.5BCalculated opportunity · +8.0% average growthHS2 84
HS2 sector 84
21 screened products with $102.4B of reported buyer imports.
$72.4BCalculated opportunity · +9.3% average growthHS2 29
HS2 sector 29
11 screened products with $53.1B of reported buyer imports.
$63.4BCalculated opportunity · +24.4% average growthFrequently asked questions
Using the Europe export playbook
Practical guidance for interpreting regional market and product comparisons.
Should Spain focus on this region?
Use the market ranking as a starting point, then check product fit, buyer requirements, route costs, tariffs, standards, and competitive conditions.
What does calculated opportunity mean?
It is a screening indicator built from demand and exporter-position signals. It is not a confirmed order, sales forecast, or guarantee of market entry.
How should exporters use this page?
Prioritize one market and product combination, then validate buyers, compliance, logistics, pricing, and continuity before making a commercial decision.
Data source
OECD trade statistics with CEPII context
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.